Maternal Mortality and the Cardiovascular Silence Around It

The United States has the highest maternal mortality rate among high-income nations, with cardiovascular disease responsible for over one quarter of pregnancy-related deaths. Black women face mortality rates 3.5 times higher than White women, a disparity that persists across education and income levels. The 2021 AHA scientific statement on cardiovascular maternal mortality identified 80% of these deaths as preventable with timely intervention. This is not a resource problem. It is a recognition problem.

The United States has the highest maternal mortality rate in the developed world. Cardiovascular disease is the leading cause. Black women die at three and a half times the rate of White women. These are not statistics. They are people.

Last month, I reviewed the case of a 34-year-old woman who died 18 days after delivering her second child. She had called her obstetrician twice in the preceding week, reporting shortness of breath and leg swelling. Both times she was told this was normal postpartum recovery. She died of peripartum cardiomyopathy with a left ventricular ejection fraction of 15%. Her heart had been failing for at least two weeks. No one had listened.

Her chart sits in a file with thousands of others. The CDC Pregnancy Mortality Surveillance System has documented this pattern for decades. We know the causes. We know the timing. We know which women are most at risk. The deaths continue because the system was not built to see them.

The Numbers We Cannot Ignore

The 2021 US maternal mortality rate reached 32.9 deaths per 100,000 live births, according to the National Center for Health Statistics. This represents a 40% increase from 2019. For context, the United Kingdom reports 9.7, Germany 7.5, and Australia 6.0 per 100,000. The United States is not merely underperforming. It is an outlier. 5 / Solid

Within this crisis, cardiovascular disease dominates. The CDC Pregnancy Mortality Surveillance System data from 2017 to 2019 identifies cardiovascular conditions as responsible for 26.4% of pregnancy-related deaths. This surpasses hemorrhage at 13.4% and infection at 12.6%. Mendez-Figueroa and colleagues further analyzed cardiovascular maternal deaths and found cardiomyopathy as the single largest category, followed by hypertensive heart disease, arrhythmias, and aortic dissection.

The timing pattern is critical. Over half of cardiovascular maternal deaths occur postpartum, with the highest concentration between 7 and 42 days after delivery. This is precisely when US healthcare abandons women. The standard postpartum visit occurs at 6 weeks. Many women never make it. Insurance coverage often ends at 60 days. The system creates a surveillance gap during the period of maximum cardiac vulnerability.

Kuklina and colleagues documented cardiovascular severe maternal morbidity at delivery hospitalization and found that near-miss events outnumber deaths by 50 to 1. For every woman who dies, fifty others survive with organ damage, prolonged hospitalization, or permanent disability. The maternal mortality rate captures only the visible portion of the crisis.

The Physiology of Pregnancy as Cardiac Stress

Pregnancy is a cardiovascular stress test that no cardiologist would approve. Blood volume increases by 45% to 50%. Cardiac output rises by 30% to 50%. Heart rate increases by 10 to 20 beats per minute. The heart remodels, with left ventricular mass increasing by 12%. These changes peak in the third trimester and early postpartum period, creating maximum demand on a cardiovascular system that may harbor undetected disease.

Regitz-Zagrosek and colleagues described the hemodynamic mechanisms that transform pregnancy into a life-threatening event for women with cardiovascular vulnerability. Women with undiagnosed hypertension develop severe preeclampsia. Women with genetic cardiomyopathy variants decompensate under volume load. Women with unrecognized Marfan syndrome suffer aortic dissection at the moment of maximum aortic wall stress.

The four dominant mechanisms of cardiovascular maternal death form what I call the Maternal Cardiac Failure Cascade.

First, hypertensive disorders of pregnancy, including preeclampsia and eclampsia, cause stroke, heart failure, and HELLP syndrome. These conditions killed more women in 2020 than in 2015 despite decades of research on prevention. The issue is not knowledge. It is implementation. Severe hypertension protocols exist. Many hospitals do not follow them.

Second, peripartum cardiomyopathy strikes previously healthy women, typically in the last month of pregnancy or the first five months postpartum. The ejection fraction drops below 45%. The heart dilates. Without treatment, mortality reaches 10% at one year. With appropriate therapy including beta-blockers, ACE inhibitors, and sometimes bromocriptine, most women recover cardiac function. The challenge is recognition. The symptoms, including fatigue, shortness of breath, and leg swelling, overlap with normal pregnancy.

Third, arrhythmias cause sudden cardiac death, particularly in women with previously asymptomatic congenital heart disease or channelopathies. Pregnancy increases arrhythmia burden through hormonal effects on ion channels and the hemodynamic stress of increased preload.

Fourth, aortic dissection, often in women with undiagnosed connective tissue disorders or chronic hypertension, presents with tearing chest pain radiating to the back. The mortality rate exceeds 50% when diagnosis is delayed beyond 24 hours.

The Racial Disparity That Defines American Medicine

Black non-Hispanic women die at a rate of 55.3 deaths per 100,000 live births. White non-Hispanic women die at 19.1 per 100,000. This is a 2.9-fold disparity overall. For women aged 40 and older, the Black mortality rate is 3.5 times higher. Petersen and colleagues documented that this gap persists across education levels. A Black woman with a college degree has higher maternal mortality than a White woman who did not finish high school.

This disparity is not genetic. It is structural.

Black women report that their symptoms are dismissed more frequently. Black women with preeclampsia receive delayed treatment compared to White women with identical blood pressures. Black women presenting with chest pain in the emergency department wait longer and receive fewer diagnostic tests. The implicit bias literature documents these patterns across hundreds of studies. The maternal mortality data shows their consequences.

Women don’t die from what they have. Women die from what they hold.

The physiological toll of chronic racism, termed weathering by Arline Geronimus, manifests as accelerated cardiovascular aging. A 30-year-old Black woman may have the vascular health of a 40-year-old White woman due to cumulative stress exposure. This biological embedding of social adversity creates higher baseline cardiovascular risk entering pregnancy. When you add inadequate surveillance, dismissed symptoms, and delayed treatment, the mortality gap is not a mystery. It is a predictable outcome of a system that values some lives more than others.

I have watched this play out in my own practice. Black women who present with legitimate cardiac symptoms are told to lose weight. Black women who report palpitations are prescribed anxiety medication without an ECG. Black women who describe shortness of breath are sent home with reassurance. When they return in extremis, we express surprise. We should not be surprised. We created this.

The Eighty Percent That Are Preventable

The 2021 AHA scientific statement on cardiovascular-related maternal mortality concluded that 80% of these deaths are preventable. This is not a hopeful estimate. It is an indictment. We have the knowledge, the treatments, and the resources. We lack the systems and the will.

Preventability has specific components. Recognizing severe hypertension and treating it within 60 minutes can prevent stroke. Obtaining an echocardiogram in any postpartum woman with unexplained dyspnea can diagnose peripartum cardiomyopathy before decompensation. Providing extended postpartum cardiovascular surveillance can catch the deaths that occur after the 42-day window. Each of these interventions is simple. Each saves lives. Each is inconsistently applied.

The California Maternal Quality Care Collaborative implemented a cardiovascular bundle including standardized protocols for severe hypertension treatment. Maternal mortality from preeclampsia dropped by 21% in participating hospitals. This is the proof of concept. The challenge is scaling it nationwide.

Policy failures compound clinical failures. In states that have not expanded Medicaid, low-income women lose insurance coverage at 60 days postpartum. They lose it precisely when cardiovascular risk peaks. The American Rescue Plan provided federal funding for states to extend postpartum Medicaid to 12 months. As of 2024, only 38 states have implemented this extension. The remaining 12 states have decided, through inaction, that maternal lives are not worth the investment.

What Must Change

The clinical interventions are clear. Every woman with a hypertensive disorder of pregnancy needs cardiac monitoring extending to one year postpartum. Every woman with unexplained dyspnea, chest pain, or tachycardia in the peripartum period needs an echocardiogram and BNP. Every labor and delivery unit needs a severe hypertension protocol with mandatory treatment within 60 minutes of documented blood pressure above 160/110. These are not aspirational goals. They are minimum standards of care.

The policy interventions are equally clear. Medicaid coverage must extend to 12 months postpartum in all states. Maternal Mortality Review Committees need standardized cardiovascular expertise and mandatory reporting. Hospital quality metrics must include maternal cardiovascular outcomes with public reporting. Implicit bias training must move beyond annual checkboxes to measurable changes in care disparities.

The cultural change is harder but essential. We must stop treating pregnancy as a naturally occurring event that only occasionally goes wrong. Pregnancy is a high-risk cardiovascular state that requires surveillance, early intervention, and sustained follow-up. The framework shift is from reactive to proactive. From dismissive to vigilant. From assuming wellness to actively excluding disease.

For individual clinicians, the action is immediate. When a pregnant or postpartum woman reports symptoms, believe her. Document the differential diagnosis. Order the tests. Do not reassure without evidence. Do not send home without a safety net. The deaths occur in the gaps between visits, the symptoms attributed to normal pregnancy, the concerns dismissed as anxiety.

For patients, the action is self-advocacy coupled with documentation. If you experience chest pain, shortness of breath at rest, palpitations with near-syncope, or severe headache with visual changes, go to the emergency department. Say the words: “I am concerned about a pregnancy-related cardiac emergency.” Document the date, time, and response. If your concerns are dismissed, request that the dismissal be documented in your chart. Ask for a copy. Follow up in writing.

The Accountability We Owe

I keep a list. Not officially, and not in any system, but in my own record. Names of women whose deaths I reviewed through mortality committees and case conferences. Their cases teach me more than any textbook. Each one reveals a point of intervention that was missed, a symptom that was dismissed, a protocol that was not followed.

The 34-year-old with peripartum cardiomyopathy. The 28-year-old with preeclampsia whose magnesium was delayed. The 41-year-old with an aortic dissection who presented to an emergency department that did not have CT angiography capability. The 26-year-old with sudden cardiac death from a channelopathy that no one had ever tested for.

They were daughters, colleagues, mothers. They trusted the medical system to care for them during the most vulnerable period of their lives. The system failed them not because medicine lacks the knowledge, but because the structures to apply that knowledge consistently do not exist.

The United States spends more on healthcare than any nation on earth. We have more cardiologists per capita than any comparable country. We have the technology, the drugs, the interventional capabilities. We have everything except the collective decision to make maternal survival a priority.

Cardiovascular maternal mortality is a choice. Not the choice of individual women. Not the choice of individual clinicians. The choice of a society that has decided, through policy and practice, that this death rate is acceptable.

It is not acceptable.

The next time you hear that a woman died in childbirth in the United States, ask what killed her. The answer, more often than not, will be her heart. And the answer, more often than not, will be that her death was preventable.

Frequently Asked Questions

Why is cardiovascular disease the leading cause of maternal death in the US?

Pregnancy creates extreme cardiovascular demands. Blood volume increases by 50%. Cardiac output rises by up to 50%. These changes unmask previously silent heart disease, accelerate hypertensive disorders, and stress genetic vulnerabilities in cardiac structure and rhythm. The cardiovascular system is tested more intensively during pregnancy and the postpartum period than at any other time in a woman’s life. When the system has undetected weakness, pregnancy exposes it. When surveillance ends at 6 weeks postpartum while cardiovascular risk continues for 12 months, women die in the gap.

Why do Black women die at higher rates during pregnancy?

The disparity is not explained by genetics, income, or education. Black women with college degrees have higher maternal mortality than White women without high school diplomas. The causes are structural: chronic stress from racism accelerates cardiovascular aging, implicit bias in healthcare leads to delayed treatment and dismissed symptoms, and unequal access to high-quality obstetric and cardiac care compounds these factors. Black women with preeclampsia wait longer for treatment. Black women reporting cardiac symptoms receive fewer diagnostic tests. The disparity is measurable, documented, and the direct result of how the American healthcare system treats Black women.

What cardiac warning signs during pregnancy require immediate evaluation?

Five symptoms require same-day evaluation: chest pain or pressure, especially with exertion or at rest; shortness of breath that occurs lying flat or awakens you from sleep; resting heart rate consistently above 120 beats per minute; fainting or near-fainting episodes; and sudden severe swelling in one or both legs. Do not accept reassurance that these symptoms are normal pregnancy. Request an ECG, BNP level, and echocardiogram if indicated. If your concerns are dismissed, request documentation of the clinical reasoning in your chart.

How long after delivery can cardiovascular complications occur?

The high-risk period extends to one year postpartum. Peripartum cardiomyopathy can present up to five months after delivery. Stroke from postpartum preeclampsia can occur up to six weeks after delivery. Sudden cardiac death from arrhythmia can occur at any time. The current US standard of a single postpartum visit at six weeks with insurance coverage ending at 60 days creates a surveillance void during peak risk. Women with hypertensive disorders, gestational diabetes, or preterm delivery need cardiac monitoring for at least 12 months.

What policy changes could reduce cardiovascular maternal deaths?

The evidence-based interventions are specific. Extended Medicaid coverage to 12 months postpartum would maintain insurance during the highest-risk period. Mandatory severe hypertension treatment protocols in all labor and delivery units would reduce stroke deaths. Universal cardiac screening for women with preeclampsia would identify those needing long-term cardiovascular surveillance. Implicit bias training with measurable outcomes and accountability would address the racial disparity. Hospital quality metrics that include maternal cardiovascular outcomes with public reporting would create institutional incentives for improvement.

At your next prenatal or postpartum visit, hand your provider this list of questions: What is my blood pressure trend? Have I had any cardiac symptoms that need evaluation? What is my plan for cardiovascular monitoring after delivery? Do I have any pregnancy complications that require long-term cardiac surveillance? Write down the answers. If you experience chest pain, severe shortness of breath, or palpitations, do not wait for your next scheduled visit. Go to the emergency department and say: “I am concerned about a pregnancy-related cardiac emergency.” Your life depends on being heard.